ZETA Group acquires SIGMA to boost pharmaceutical automation

The acquisition by ZETA provides numerous benefits to customers in the field of process automation. As an established expert in this field, SIGMA now has access to an extensive network, resources, and expertise within the group. This guarantees an expanded portfolio of solutions and services with shorter processing times.

Andreas Marchler, CEO of ZETA Group, emphasized that the collaboration between ZETA and SIGMA allows customers to benefit from an exceptional combination of expertise and experience drawn from both companies. This strategic partnership is designed to maximize value for clients through shared resources and know-how.

The three CEOs of SIGMA—Martin Spinnler, Jochen Hasselbach, and Gerald Dollberger—highlighted their joint commitment to providing a strong network and comprehensive services that are closely aligned with customer needs. Their unified approach reinforces the customer-centric philosophy at the heart of the collaboration.

With the addition of Axel Thomas, a long-standing SIGMA employee, to the management team, ZETA and SIGMA have established a highly experienced and capable leadership group. This team is well-positioned to further strengthen the companies’ market presence in the areas of process automation and digitalization.

The combined expertise of ZETA and SIGMA is now available to all customers, drawing upon a strong network of over 300 experts in process automation and digitalization. Comprehensive automation competence can be found in the DACH (Germany, Austria, Switzerland) region at 11 locations in close proximity to important industrial centers.

The three managing directors—Martin Spinnler, Jochen Hasselbach, and Gerald Dollberger—shared a unified message to the market.

“The message to the market is clear: when it comes to custom automation solutions – from individual systems to extensive process control systems – there is no way around ZETA and SIGMA.”